| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors
|
Mateo, J.
|
|
2014
|
74 |
5 |
p. 1039-1046
|
artikel
|
| 2 |
Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases
|
Kodama, Tatsushi
|
|
2014
|
74 |
5 |
p. 1023-1028
|
artikel
|
| 3 |
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms
|
Figg, William D.
|
|
2014
|
74 |
5 |
p. 955-967
|
artikel
|
| 4 |
A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors
|
Becerra, Carlos R.
|
|
2014
|
74 |
5 |
p. 917-925
|
artikel
|
| 5 |
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
|
Slingerland, Marije
|
|
2014
|
74 |
5 |
p. 1089-1098
|
artikel
|
| 6 |
A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer
|
Nakai, Yousuke
|
|
2014
|
74 |
5 |
p. 911-915
|
artikel
|
| 7 |
Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients
|
Fabre, Claire
|
|
2014
|
74 |
5 |
p. 1057-1064
|
artikel
|
| 8 |
Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program
|
Lee, Jae-Lyun
|
|
2014
|
74 |
5 |
p. 1005-1013
|
artikel
|
| 9 |
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)
|
Beumer, Jan H.
|
|
2014
|
74 |
5 |
p. 927-938
|
artikel
|
| 10 |
Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutation
|
Igawa, Satoshi
|
|
2014
|
74 |
5 |
p. 939-946
|
artikel
|
| 11 |
Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance
|
Lingeman, Robert G.
|
|
2014
|
74 |
5 |
p. 981-993
|
artikel
|
| 12 |
GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)
|
Poveda, Andrés
|
|
2014
|
74 |
5 |
p. 883-898
|
artikel
|
| 13 |
Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation
|
Patel, Kirtesh
|
|
2014
|
74 |
5 |
p. 1015-1022
|
artikel
|
| 14 |
Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy
|
Kanekawa, Takenori
|
|
2014
|
74 |
5 |
p. 899-909
|
artikel
|
| 15 |
Leucovorin rescue allows effective high-dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenografts
|
Tedeschi, Philip M.
|
|
2014
|
74 |
5 |
p. 1029-1032
|
artikel
|
| 16 |
Mechanistic pharmacokinetic/pharmacodynamic modeling of in vivo tumor uptake, catabolism, and tumor response of trastuzumab maytansinoid conjugates
|
Wada, Russ
|
|
2014
|
74 |
5 |
p. 969-980
|
artikel
|
| 17 |
Non-surgical treatment versus radical esophagectomy for clinical T1N0M0 esophageal carcinoma: a single-center experience
|
Park, Inkeun
|
|
2014
|
74 |
5 |
p. 995-1003
|
artikel
|
| 18 |
Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastoma
|
Desai, Ami V.
|
|
2014
|
74 |
5 |
p. 1047-1055
|
artikel
|
| 19 |
Phase I trial of hepatic arterial infusion (HAI) of floxuridine with modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresectable liver metastases from colorectal cancer
|
Li, Cong
|
|
2014
|
74 |
5 |
p. 1079-1087
|
artikel
|
| 20 |
Predicting success in regulatory approval from Phase I results
|
Malik, Laeeq
|
|
2014
|
74 |
5 |
p. 1099-1103
|
artikel
|
| 21 |
Prognostic value of human papillomavirus in anal squamous cell carcinoma
|
Ravenda, Paola Simona
|
|
2014
|
74 |
5 |
p. 1033-1038
|
artikel
|
| 22 |
Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients
|
Tulsyan, Sonam
|
|
2014
|
74 |
5 |
p. 1065-1078
|
artikel
|
| 23 |
TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial
|
Erhardt, Andreas
|
|
2014
|
74 |
5 |
p. 947-954
|
artikel
|
Tijdschrift beschrijving